Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord. 2011 Dec; 135(1-3):389-94.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.